PharmAust (ASX: PAA) ready to trial monepantel on humans to fight motor neurone disease (w/ Dr Roger Aston)

PharmAust (ASX: PAA) executive chairman and CEO Dr Roger Aston joins Small Caps to discuss the latest news in relation to its lead drug...